logo
Barbara Kay: Antisemitism plagues Canadian medical schools. It isn't healthy

Barbara Kay: Antisemitism plagues Canadian medical schools. It isn't healthy

Yahoo25-05-2025
Universities are ground zero for the most virulent strains of antisemitism that plague the West today. But within them, some clusters are more problematic than others. Above all, the widespread antisemitism in university faculties of medicine and affiliated hospitals.
Simmering for decades in these departments, the October 7 pogrom unleashed a dramatic surge in its expression amongst students, faculty and practitioners that cries out for attention at the highest levels.
Research on this subject is accumulating. It's essentially a borderless issue, as becomes clear in the international perspective undertaken in an April report by Israel's Rambam Maimonides Medical Journal, which compares the experiences of Jewish medical personnel in Canada, the United Kingdom, Australia, and the U.S.
One Canadian example at the Faculty of Medicine of the University of British Columbia (UBC) describes the 1930s-Germany vibe common in Canada's largest medical faculties:
'Social media posts vilifying Israel and espousing Jew hatred were circulated by physicians at the Faculty of Medicine of the University of British Columbia after the October 7 massacre. Allegations included Christ-killing, organ trafficking, and other nefarious conspiracies supposedly hatched by Jewish doctors. Some asserted that Jewish faculty should not be allowed to adjudicate resident matching because the examining doctors were Jewish and might be racist.'
It gets worse.
When three hundred Jewish students signed a letter expressing concern about UBC's tolerance of Jew hatred, 'the Dean of the medical faculty refused to recognize antisemitism as a problem at UBC or to meet with (their) representatives.'
This refusal to address antisemitism in the faculty led to the public resignation of Dr. Ted Rosenberg, a senior Jewish faculty member, last January.
'Sadly,' the report authors conclude, reported experiences by Jewish physicians 'are mostly congruent and illustrate the existence and degree of antisemitism and anti-Zionism expressed toward healthcare providers in their respective countries.'
As a result, a career in medicine, where Jews have disproportionately flourished for so long, is losing its lustre.
The Jewish Medical Association of Ontario (JMAO) conducted a 2024 survey, which has yet to be published, of 944 Jewish doctors and medical students from across Canada. Two thirds of respondents were 'concerned that antisemitic bias from peers or educators will negatively affect their careers.'
JMAO organizers pronounced themselves 'stunned' to discover 80 per cent of respondents — about 380 people — had faced antisemitism at work since October 7, 39 per cent in hospitals and 43 per cent in academic institutions. Thirty-one per cent of respondents from Ontario — about 150 people — are considering emigrating to the U.S. or Israel on that account.
Dr. Lisa Salomon, JMAO's president, told me via email that while enrolment decline of Jewish students could reflect other factors, the anecdotal evidence is 'deeply concerning.'
According to Salomon, 'At the University of Toronto — the largest medical school in Ontario and located in the city with the largest Jewish population in Canada — we estimate that only 11 Jewish students are currently completing their first year of medical school out of a class of 291. This is approximately half the number of Jewish students in the previous year's class….' (For historical contrast, a physician friend who graduated from U of T's medical school in 1974 was one of 46 Jews in a class of 218.)
Grassroots Canadian organizations like Doctors Against Racism and Antisemitism (DARA) (on whose honorary board I sit) have provided a cornucopia of evidence that the situation for Jews at the U of Toronto's Temerty Faculty of Medicine has become dire.
DARA has pushed back with dynamism and moral clarity for years: petitions, open letters to deans and university presidents, political activism. But quelling this rapidly spreading epidemic will take measures that voluntary organizations do not have the authority to impose.
The worst news on this front is that the problem may be insoluble.
On May 18, Tablet Magazine published an article with the provocative title, 'Ask your doctor if Jihad is right for you.' The more sober subheading declares that American medicine's antisemitism problem is 'driven by foreign-trained doctors importing the Jew-hatred of their native countries.'
The article's authors, Jay P. Greene, and Ian Kingsbury, respectively a Senior Fellow at Do No Harm, a health care advocacy non-profit, and its director, conducted research based on data amassed by the organization Stop Antisemitism. Their findings project a grim future for healthcare.
The authors identified a 'set of over 700 people from all walks of life profiled by Stop Antisemitism for displaying flagrant hostility toward Jews and Israel.' They found that doctors were 'almost 26 times overrepresented in the list of antisemites relative to their prevalence in the workforce.' Half of the Jew-hating doctors 'received their medical degrees abroad,' many in the Middle East or Pakistan, where open expression of extreme antisemitism is considered 'appropriate or even enlightened.' Homegrown cosplaying revolutionaries, imbued with DEI-based revulsion from Zionism, follow their lead.
As in the U.S., where the Trump administration is currently investigating antisemitism within the medical faculties at four elite universities, Canada needs more doctors than can be domestically sourced. We will therefore continue to welcome medical students, residents and practitioners from regions where antisemitism is a cultural norm.
Only a small fraction of them will choose to fan flames of hate against their Jewish colleagues. But that small fraction, supported by international entities bent on dangerous mischief, is enough to sow high anxiety in a targeted community that, on this file above all others, wasn't born yesterday.
kaybarb@gmail.com
X: @BarbaraRKay
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Doctors are seeing more non-smokers, especially women, with later-stage lung cancer
Doctors are seeing more non-smokers, especially women, with later-stage lung cancer

Yahoo

time4 hours ago

  • Yahoo

Doctors are seeing more non-smokers, especially women, with later-stage lung cancer

TORONTO — Katie Hulan's family doctor thought she might have asthma. Her cough, which had started about a month and a half earlier, was getting progressively worse. So he gave her some puffers to try, but they didn't work. "I was just getting to the point where I couldn't speak at work," said the 37-year-old tech marketing manager. "At the end of the day, I would be in pain just from the shaking and coughing." Her doctor ordered an X-ray that showed a mass on her lung. "(My doctor) said to go to emergency, thinking it was a blood clot," Hulan remembers. After about six hours of more tests, they told her she had stage 4 lung cancer. "That was one of the most devastating moments of my life," she said. "My immediate reaction was, 'I know how this story ends.' And so for me, it just felt completely like a death sentence." She had been healthy, active and didn't smoke. "For me to get a cancer diagnosis was a big shock. And then to have a lung cancer diagnosis was very puzzling for me," said Hulan, who was diagnosed in Toronto in late 2020 and has since moved to Victoria where she continues treatment. She's one of a growing number of non-smokers doctors are seeing with lung cancer. Although smoking remains the leading risk factor, the Canadian Cancer Society estimates about a quarter of lung cancer cases in the country are non-smokers. In addition, more of those non-smokers are women than men and it's not clear why, said Jessica Moffatt, vice-president of programs and advocacy at the Lung Health Foundation. "One of the theories is that potentially estrogen is doing something to perpetuate tumour growth, but it's all theories at this point," she said. What scientists do know is that environmental factors contribute to lung cancer risk, especially radon gas. According to Health Canada, long-term exposure to radon — an invisible, radioactive gas from the breakdown of uranium in soil and rocks — is the number one cause of lung cancer among non-smokers. The agency says radon is present to some degree in every home and urges everyone to get a radon test kit to check their levels. Other risk factors include exposure to second-hand smoke, asbestos and the fine particulate matter in air pollution, Moffatt said. As wildfires rage across the country, the effects of that smoke is "a huge concern for us" and is an area being studied to determine lung cancer risk, she said. Dr. Rosalyn Juergens, a medical oncologist at McMaster University and Hamilton Health Sciences Centre, said studies have shown that people living in areas with high air pollution rates have a higher risk of developing lung cancer. Over about 20 years in practice, she has "absolutely" seen a rise in non-smoking lung cancer patients. "It was uncommon for me, not never, but uncommon for me, to see a never-smoker when I first started in practice. And we are definitely seeing more and more," said Juergens, who is also the president of Lung Cancer Canada. It's not clear whether there are more non-smokers getting lung cancer or if they just make up a greater proportion of the patients as fewer people smoke than ever before, she said. Many of her non-smoking patients are women, but people simply aren't aware of lung cancer as a women's health issue, she said. When non-smokers reach her office, their cancer is often in advanced stages. "More women will die of lung cancer than will die of breast cancer, ovarian cancer, and cervical cancer combined," Juergens said. "One in five of them will be people who have never touched a cigarette a day in their lives." Although organized lung cancer screening programs have been running in British Columbia, Ontario and Nova Scotia since 2022, they only target smokers, so non-smokers don't get the benefit of that early detection. In addition, lung cancer is often not top-of-mind for primary-care providers when non-smoking patients come in with a cough, Juergens said. "The tricky part about lung cancer is symptoms are generally very subtle, right? Your lungs inside don't have nerve endings. So it's not like you're going to get a pain. You're never going to feel a lump," she said. But the good news for many patients, Juergens said, is that lung cancer treatment has advanced dramatically since the 1990s, when chemotherapy was often the only option. "We do things called next generation sequencing on the vast majority of lung cancers, and that helps us to sort what exact type of lung cancer it is and pick the right treatments," she said. That precision medicine turned Katie Hulan's initial life expectancy of six months into an average of five to six years. A biopsy showed that her cancer had an ALK genetic mutation — one of about a dozen biomarkers that have specific medications to target the cancerous cells, and is only present in about four per cent of cases. "When I got that news, it felt like a 180. I had life. I had hope. You know, my oncologist sat down and said, 'you won the lottery, you have years,'" she said. Almost five years after her diagnosis, Hulan continues to take a pill as her treatment, never had to undergo chemotherapy, feels "wonderful" and is determined to live a long, full life. She now does advocacy work for the Lung Health Foundation to call for equal access to targeted cancer medication across the country and to urge people to seek medical attention if they have a cough that lasts more than two or three weeks. "I think the word on the street is that you have to be a person who has smoked and that's not at all the case," she said. "Anyone with lungs can get lung cancer." This report by The Canadian Press was first published Aug. 18, 2025. Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content. Nicole Ireland, The Canadian Press

I'm in my 60s — I put this $13 'Botox in a bottle' from a Canadian brand to the test
I'm in my 60s — I put this $13 'Botox in a bottle' from a Canadian brand to the test

Yahoo

time4 hours ago

  • Yahoo

I'm in my 60s — I put this $13 'Botox in a bottle' from a Canadian brand to the test

Shoppers are obsessed with this affordable anti-aging product. But does it live up to the hype? Aging is a natural part of life, but if you're not so into fine lines and wrinkles, you might want to check out The Ordinary's Argireline Solution 10% Serum for Facial Wrinkles. The Canadian company's serum has been dubbed "Botox in a bottle" by shoppers, and the best part? It's super affordable, ringing in at under $15. The brand's website categorizes it as a "non-injective solution for dynamic lines" specifically designed to target signs of aging. The serum almost seems too good to be true, so both my mom — who's in her 60s — and I decided to put it to the test to see if it lives up to the claims. Scroll down for our honest review. The Ordinary Argireline Solution 10% Serum for Facial Wrinkles review: What is it and what are the claims? The Ordinary's Argireline Solution serum is formulated to target skincare concerns such as fine lines and wrinkles, thanks to an Argireline Peptide Complex. As outlined on Sephora, this complex allegedly helps improve the overall appearance of the eye area and forehead, which are two prominent spots on the face that are most prone to creasing or developing folds in the skin. This affordable serum also features a lightweight texture. For best results, it's recommended to apply a few drops to the forehead and around the eye area twice a day. As The Ordinary's website suggests, you can incorporate this product into your routine after cleansing and before applying any anhydrous serums, oils, suspensions, or creams. also recommends avoiding the use of products featuring Direct acids, Direct/Ethylated Vitamin C, and Resveratrol 3% + Ferulic Acid 3% in the same skincare regimen as The Ordinary's Argireline Solution contains Peptides. First impressions As someone in her 60s, my mom is always on the hunt for new products to help target fine lines and wrinkles, so she was excited to give The Ordinary's Argireline Solution a go. This was her skin in the morning before she applied the serum — right after cleansing. She then applied a few drops of the Argireline Solution to her forehead and around the eye area, as recommended. Although she didn't notice a drastic physical change, my mom did note that the product felt tightening upon application, firming her skin after use. Best of beauty: I'm a dermatologist — 3 'universal' skincare staples I always recommend for anti-aging Cheekbone Beauty is Canadian, Indigenous-owned and sustainable — and these celebrities are 'adamant' about using it I'm a celebrity esthetician — this is the 'gold standard' for anti-aging Then, it was my turn. As a 27-year-old, I have always been curious about elevating my skincare routine and have become increasingly interested in finding preventative products that can reduce the look of fine lines as I age. As a result, I was eager to put The Ordinary's Argireline Solution to the test to see if it would actually work on both young and mature skin. Similarly to my mom, I applied a few drops of the lightweight serum to my forehead and eye area after cleansing. I, too, immediately noticed a tightening sensation after application but no immediate physical results- except for my skin appearing to look slightly smoother. It's important to note that it is recommended to use this product twice daily, so we will likely see improved results through more consistent use. What shoppers are saying This affordable serum has a 4-star rating on Sephora, based on more than 400 customer reviews. "Love this product," raved one shopper who deemed it "a staple" for them. "I'm on my third bottle," they added. One 72-year-old customer who has "spent thousands on expensive products" said, "I believe I found the holy [grail with] this stuff!" They said that after "a few weeks," their "fine lines have lessened," and their "deeper lines have softened" — even their "neck wrinkles." However, other shoppers claimed to have not seen any "noticeable improvements" after use, alleging that the product does not minimize the appearance of wrinkles as claimed. Is it worth it? It's worth noting that some skincare solutions take a couple of weeks to perform, so we decided to consistently use this product day and night, as recommended, to see if it garners any notable results. Consistency seems to be key when it comes to The Ordinary's Argireline Solution, as verified by other Sephora shoppers who have used and loved the product. Here's what we noticed after diligently using The Ordinary's Argireline Solution day and night for the past two weeks: Although my mom didn't notice a significant physical difference in her appearance, she did note that her skin felt smoother. For the price, she found that The Ordinary's Argireline Solution was definitely worth a try, and she will continue to use the product to monitor how her skin looks over time. After two weeks of consistent use, I, too, didn't notice a huge difference in the way my skin looked. However, I don't have excessive fine lines or wrinkles, so I may consider this to be more of a preventative skincare product in my everyday beauty routine. That said, I did appreciate how smooth my skin felt after use. I agree that this product is worth the hype in terms of the price tag if you're looking for an affordable way to improve skin smoothness and firmness. Even though it truthfully may be too early to claim that this product is "Botox in a bottle," our opinions may change after more consistent use, so we recommend giving it a fair shot (no pun intended) if you're looking to try it out yourself — especially for $13.

City rejects claims by family of victim killed after man fell from Leaside Bridge
City rejects claims by family of victim killed after man fell from Leaside Bridge

Yahoo

time4 hours ago

  • Yahoo

City rejects claims by family of victim killed after man fell from Leaside Bridge

WARNING: This story contains discussion of suicide. The City of Toronto is arguing that a lawsuit filed by the family of a man who died after being crushed by another man who fell from the Leaside Bridge last year should be dismissed. In a statement of defence filed at the Ontario Superior Court of Justice last month, the city denies all claims in the lawsuit brought by the family of 76-year-old Harold Lusthouse and denies any liability in his death. According to the family, Lusthouse was a passenger in a moving car on June 16, 2024, when a man fell or jumped from the bridge toward the Don Valley Parkway and landed on the car, fatally injuring Lusthouse. Lusthouse died in hospital days after the incident. The family, which is seeking $1.7 million and potential future legal costs, is suing the city for the lack of suicide barriers on the bridge, alleging they would have prevented Lusthouse's death. No 'private duty of care' owed, city argues In its statement of defence, the city denies it owes a "private duty of care" to Lusthouse. It also says it is protected by the City of Toronto Act, which states that no action will be brought against the city for damages caused by the "presence, absence or insufficiency" of a wall, fence, rail or barrier along any highway. According to the city, Toronto city council's executive committee received a report in 2018 from the Toronto medical officer of health that advised that barriers on city bridges, including the Leaside Bridge, were to be assessed through feasibility studies and any work recommended would be done in conjunction with state-of-good-repair bridge work likely in or after 2028. In 2023, the city's transportation services division began a feasibility study for the Leaside Bridge. The city notes that Lusthouse's death occurred before that study was completed and before the bridge was due for any state-of-good-repair work. Highways in 'reasonable state of repair,' city argues The city also argues that even if it owed Lusthouse a duty of care, the legal action would be inadmissible under section 390 of the City of Toronto Act, which it says provides immunity if a policy decision is made in good faith. It says a decision to install suicide barriers on the Leaside Bridge would have been a policy decision made by the city. "The decision involves the allocation of millions of dollars and requires an evaluation of, among other things, the public purpose and efficacy of such barriers; the bridge's structural integrity; the resources required to ensure future maintenance of the infrastructure; and the balancing of these considerations with other pressing issues faced by the City given its finite resources," the statement of defence reads. In addition, the city argues that its highways are a "reasonable state of repair" and it is not compelled to take "any and all" actions to prevent accidents, including this accident, from occurring. "The fact that an accident is possible does not require a municipality, which must allocate finite resources, to take any and all conceivable measures to prevent such an accident. The City need only take reasonable steps to ensure the state of repair of its highways, which steps are informed by policy considerations, including but not limited to considerations of distributing scarce and finite resources," the statement of defence reads. The city is asking that the lawsuit be dismissed with costs. If you or someone you know is struggling, here's where to get help:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store